The prognostic value of epidermal growth factor receptor (EGFR) expression and its biological role in estrogen receptorpositive (ER+) and ER-negative (ER-) primary breast cancer is controversial. In this study, distributions of ER, progesterone receptor and EGFR have been established using immunohis
Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer
โ Scribed by Toshiaki Mori; Tadaoki Morimoto; Kansei Komaki; Yasumasa Monden
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 504 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Epidermal growth factor (EGF) receptor status is a useful prognostic indicator in women with breast cancer. Lack of standardization and correlation of methodology for the detection of EGF receptor has hampered its further evaluation. EGF receptor status was ascertained by immunohistoche
Bearing in mind the continuing controversy over the prognostic significance of epidermal growth factor receptor (EGF-r) expression, we investigated its clinical significance prospectively in 345 primary breast cancer patients. The prognostic significance of EGF-r expression, as measured by a radioli
## Background: Over-expression of human epidermal growth factor receptor (egfr) is associated with a variety of human malignancies, including head and neck cancer. it has also been studied for its effect on cancer cell responses to chemotherapy. to accurately measure changes in egfr expression that